Suchbegriffe: FLUCONAZOLE - PHARMACOLOGY , . Treffer: 3
Knoll, MA; Lackner, N; Ulmer, H; Samardzic, E; Steinmann, J; Krause, R; Verhasselt, HL; Rath, PM; Fuchs, F; Koehler, P; Denis, B; Hamane, S; Alanio, A; Lass-Flörl, C
Multiple colony antifungal susceptibility testing detects polyresistance in clinical Candida cultures: a European Confederation of Medical Mycology excellence centers study.
Clin Microbiol Infect. 2022; 28(9):1288.e1-1288.e7
Doi: 10.1016/j.cmi.2022.04.014
Web of Science
PubMed
FullText
FullText_MUG
Buzina, W
Aspergillus--classification and antifungal susceptibilities.
Curr Pharm Des. 2013; 19(20):3615-3628
Doi: 10.2174/1381612811319200005
Web of Science
PubMed
FullText
FullText_MUG
Wenisch, C; Moore, CB; Krause, R; Presterl, E; Pichna, P; Denning, DW
Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome.
J Clin Microbiol. 2001; 39(7):2458-2462
Doi: 10.1128/JCM.39.7.2458-2462.2001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG